HIGHLIGHTS
- who: Raffaella Pasquale from the University of Udine, Italy have published the Article: Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event, in the Journal: (JOURNAL)
- what: In this case report, nilotinib was found to be the only possible cause of PE, after excluding other etiologies.
SUMMARY
BCR::ABL1-positive chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1-2 cases per 100.000 adults, which represents approximately 15% of newly diagnosed cases of leukemia in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.